Article
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
Pharmacogenetics and genomics - 1 Nov 2012
Urban Thomas J, Shen Yufeng, Stolz Andrew, Chalasani Naga, Fontana Robert J, Rochon James, Ge Dongliang, Shianna Kevin V, Daly Ann K, Lucena M Isabel, Nelson Matthew R, Molokhia Mariam, Aithal Guruprasad P, Floratos Aris, Pe'er Itsik, Serrano Jose, Bonkovsky Herbert, Davern Timothy J, Lee William M, Navarro Victor J, Talwalkar Jayant A, Goldstein David B, Watkins Paul B
Abstract excerpt
BACKGROUND AND AIMS: Drug-induced liver injury (DILI) is a serious adverse drug event that is suspected to have a heritable component. We carried out a genome-wide association study of 783 individuals of European ancestry who experienced DILI due to more than 200 implicated drugs. METHODS: DILI patients from the US-based Drug-Induced Liver Injury Network (n=401) and three international registries (n=382) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
